TrapEase vena cava filter: Experience in 751 patients

Journal of Endovascular Therapy

Volumn 13, Issue 3, 2006, Pages 365-372

  Kalva, Sanjeeva P ^a   Wicky, Stephan ^a   Waltman, Arthur C ^a   Athanasoulis, Christos A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Complications; Deep venous thrombosis; Inferior vena cava; IVC filters; Pulmonary embolism; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; CONTRAST MEDIUM; GADOLINIUM PENTETATE; HOMOCYSTEINE; IOPROMIDE; PHOSPHOLIPID ANTIBODY;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ANTITHROMBIN III DEFICIENCY; ARTICLE; BRAIN HEMORRHAGE; BURN; CANCER; CAVOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEATH; DEEP VEIN THROMBOSIS; DEVICE; FEMALE; FOLLOW UP; GENE MUTATION; HEMATOMA; HUMAN; HYPERCOAGULABILITY; INFARCTION; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTIPLE TRAUMA; PATIENT SAFETY; PICTURE ARCHIVING AND COMMUNICATION SYSTEM; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN S DEFICIENCY; RISK FACTOR; THROMBUS; TREATMENT INDICATION; VENA CAVA FILTER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTHESIS FAILURE; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; TOMOGRAPHY, X-RAY COMPUTED; VENA CAVA FILTERS; VENOUS THROMBOSIS;

EID: 33751176488     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/05-1741.1     Document Type: Article

References (25)

1. Ferreira GS, Carson JL. Diagnosis of venous thromboembolism: factors determining individual patient probabilities of deep vein thrombosis or pulmonary embolism. Curr Hematol Rep. 2003;2:423-428.
2. Lee AY, Hirsh J. Diagnosis and treatment of venous thromboembolism. Annu Rev Med. 2002;53:15-33.
3. Levine M, Raskob GE, Landefeld CS, et al. Hemorrhagic complications of anticoagulant treatment. Chest. 1998;114(suppl):511S-523S.
4. Mobin-Uddin K, McLean R, Bolooki H, et al. Caval interruption for prevention of pulmonary embolism: long-term results of a new method. Arch Surg. 1969;99:711-715.
5. Greenfield LJ, McCurdy JR, Brown PP, et al. A new vena caval filter permitting continued flow and resolution of emboli. Surgery. 1973;73:599-606.
6. Simon M, Athanasoulis CA, Kim D, et al. Simon nitinol inferior vena cava filter: initial clinical experience. Work in progress. Radiology. 1989;172:99-103.
7. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005;112:416-422.
8. Wingerd M, Bernhard VM, Maddison F, et al. Comparison of caval filters in the management of venous thromboembolism. Arch Surg. 1978;113:1264-1271.
9. Berland LL, Maddison FE, Bernhard VM. Radiologic follow-up of vena cava filter devices. AJR Am J Roentgenol. 1980;134:1047-1052.
10. Tobin KD, Pais SO, Austin CB. Femoral vein thrombosis following percutaneous placement of the Greenfield filter. Invest Radiol. 1989;24:442-445.
11. Greenfield LJ, Cho KJ, Pais SO, et al. Preliminary clinical experience with the titanium Greenfield vena caval filter. Arch Surg. 1989;124:657-659.
12. Palestrant AM, Prince M, Simon M. Comparative in vitro evaluation of the nitinol inferior vena cava filter. Radiology. 1982;145:351-355.
13. Millward SF, Bhargava A, Aquino J, et al. Gunther Tulip filter: preliminary clinical experience with retrieval. J Vasc Interv Radiol. 2000;11:75-82.
14. Mohan CR, Hoballah JJ, Sharp WJ, et al. Comparative efficacy and complications of vena caval filters. J Vasc Surg. 1995;21:235-245.
15. Lorch H, Dallmann A, Zwaan M, et al. Efficacy of permanent and retrievable vena cava filters: experimental studies and evaluation of a new device. Cardiovasc Intervent Radiol. 2002;25: 193-199.
16. Hoekstra A, Hoogeveen Y, Elstrodt J, et al. Vena cava filter behavior and endovascular response: an experimental in vivo study. Cardiovasc Intervent Radiol. 2003;26:222-226.
17. Rousseau H, Perreault P, Otal P, et al. The 6-F nitinol TrapEase inferior vena cava filter: results of a prospective multicenter trial. J Vasc Interv Radiol. 2001;12:299-304.
18. Schutzer R, Ascher E, Hingorani A, et al. Preliminary results of the new 6F TrapEase inferior vena cava filter. Ann Vasc Surg. 2003;17:103-106.
19. Liu WC, Do YS, Choo SW, et al. The mid-term efficacy and safety of a permanent nitinol IVC filter (TrapEase). Korean J Radiol. 2005;6:110-116.
20. Stavropoulos, Itkin M, Trerotola S. In vitro study of guide wire entrapment in currently available inferior vena cava filters. J Vasc Interv Radiol. 2003;14:905-901.
21. Leask R, Johnston K, Ojha M. Hemodynamic effects of clot entrapment in the TrapEase inferior vena cava filter. J Vasc Interv Radiol. 2004;15:485-490
22. Athanasoulis CA, Kaufman JA, Halpern EF, et al. Inferior vena caval filters: review of a 26-year single-center clinical experience. Radiology. 2000;216:54-66.
23. Ferris EJ, McCowan TC, Carver DK, et al. Percutaneous inferior vena caval filters: follow-up of seven designs in 320 patients. Radiology. 1993;188:851-856.
24. Mewissen MW, Erickson SJ, Foley WD, et al. Thrombosis at venous insertion sites after inferior vena caval filter placement. Radiology. 1989;173:155-157.
25. Kantor A, Glanz S, Gordon DH, et al. Percutaneous insertion of the Kimray-Greenfield filter: incidence of femoral vein thrombosis. AJR Am J Roentgenol. 1987;149:1065-1066.